Animal Health Market

Executive Summary

Animal Health Market was valued at US $55.51 billion in 2021 and is projected to grow at 4.44% CAGR over the forecast period to reach US $72.02 billion by 2027. Animal Health Market represented US $4.61 billion opportunity over 2019-2021 and estimated to create US $16.51 billion opportunity in 2027 over 2021.

Animal Health from Consainsights analyses the Animal Health Market in the Life Sciences industry over the forecast period to 2027.

Animal Health research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Animal Health segmentation includes Product, Animal, End-User and Geography.

Based on the Product, the Animal Health analysis covers Growth Promoters, Feed Additives/Nutritional Products, Vaccines, Parasiticides, Antimicrobials & Antibiotics, Other Pharmaceuticals.

In Product segment, Growth Promoters segment has highest cagr growth of 3.93%.

Based on the Animal, the Animal Health analysis covers Food Producing Animals, Companion Animals.

In Animal segment, Food Producing Animals segment has highest cagr growth of 3.93%.

Based on the End-User, the Animal Health analysis covers Animal Farms, Veterinary Hospitals & Clinics, Homecare.

In End-User segment, Animal Farms segment has highest cagr growth of 3.93%.

Based on the region, the Animal Health analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Boehringer Ingelheim, Elanco Animal Health, Merck Animal Health, Zoetis Inc., Virbac, Vetoquinol S.A., Phibro Animal Health, Ceva Santé Animale, Dechra Pharmaceuticals plc., Kyoritsu Seiyako, Tianjin Ringpu, China Animal Husbandry, Jinyu Bio-Technology, Zydus Animal Health, Hipra, Endovac Animal Health, Bovicure Pharma, Indian Immunologicals Ltd., Ashish Life Science (Als), Lutim Pharma and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Growth Promoters segment has the highest revenue of US $21.46 billion and is expected to grow at CAGR of 3.93% by 2027 Growth Promoters segment has highest cagr growth of 3.93%.

Growth Promoters

Growth Promoters segment was valued at US $19.68 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $27.85 billion by 2027. Growth Promoters segment represented US $1.78 billion opportunity over 2019-2021 and estimated to create US $6.38 billion opportunity in 2027 over 2021.

Feed Additives/Nutritional Products

Feed Additives/Nutritional Products segment was valued at US $12.02 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $17.02 billion by 2027. Feed Additives/Nutritional Products segment represented US $1.09 billion opportunity over 2019-2021 and estimated to create US $3.90 billion opportunity in 2027 over 2021.

Vaccines

Vaccines segment was valued at US $8.07 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $11.42 billion by 2027. Vaccines segment represented US $0.73 billion opportunity over 2019-2021 and estimated to create US $2.62 billion opportunity in 2027 over 2021.

Parasiticides

Parasiticides segment was valued at US $5.90 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $8.35 billion by 2027. Parasiticides segment represented US $0.53 billion opportunity over 2019-2021 and estimated to create US $1.91 billion opportunity in 2027 over 2021.

Antimicrobials & Antibiotics

Antimicrobials & Antibiotics segment was valued at US $3.23 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $4.57 billion by 2027. Antimicrobials & Antibiotics segment represented US $0.29 billion opportunity over 2019-2021 and estimated to create US $1.05 billion opportunity in 2027 over 2021.

Other Pharmaceuticals

Other Pharmaceuticals segment was valued at US $1.99 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $2.82 billion by 2027. Other Pharmaceuticals segment represented US $0.18 billion opportunity over 2019-2021 and estimated to create US $0.65 billion opportunity in 2027 over 2021.

Animal

Introduction

In 2021, Food Producing Animals segment has the highest revenue of US $34.38 billion and is expected to grow at CAGR of 3.93% by 2027 Food Producing Animals segment has highest cagr growth of 3.93%.

Food Producing Animals

Food Producing Animals segment was valued at US $31.52 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $44.61 billion by 2027. Food Producing Animals segment represented US $2.86 billion opportunity over 2019-2021 and estimated to create US $10.23 billion opportunity in 2027 over 2021.

Companion Animals

Companion Animals segment was valued at US $19.37 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $27.41 billion by 2027. Companion Animals segment represented US $1.76 billion opportunity over 2019-2021 and estimated to create US $6.28 billion opportunity in 2027 over 2021.

End-User

Introduction

In 2021, Animal Farms segment has the highest revenue of US $34.72 billion and is expected to grow at CAGR of 3.93% by 2027 Animal Farms segment has highest cagr growth of 3.93%.

Animal Farms

Animal Farms segment was valued at US $31.83 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $45.04 billion by 2027. Animal Farms segment represented US $2.89 billion opportunity over 2019-2021 and estimated to create US $10.33 billion opportunity in 2027 over 2021.

Veterinary Hospitals & Clinics

Veterinary Hospitals & Clinics segment was valued at US $12.61 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $17.85 billion by 2027. Veterinary Hospitals & Clinics segment represented US $1.14 billion opportunity over 2019-2021 and estimated to create US $4.09 billion opportunity in 2027 over 2021.

Homecare

Homecare segment was valued at US $6.45 billion in 2019 and is projected to grow at 3.93% CAGR over the forecast period to reach US $9.13 billion by 2027. Homecare segment represented US $0.58 billion opportunity over 2019-2021 and estimated to create US $2.09 billion opportunity in 2027 over 2021.